Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities
Abstract
Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.
Full citation:
Hagan H, Latka MH, Campbell JV, Golub ET, Garfein RS, Thomas DA, Kapadia F, Strathdee SA, Study to Reduce Intravenous Exposures Project Team (2006). Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities
Clinical Infectious Diseases, 42 (5), 669-672. doi: 10.1086/499951.